Elizabeth Bozeman, MD
Urology · Florence, SCNPI 1891751764
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by AbbVie at 41.9% of the total. Reporting peaked in 2021 at $18,638 and has fallen 97.0% since, to $560 in 2025. Among urology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 401 payments — averaging $141.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$24K
- Axonics, Inc.$14K
- Urovant Sciences Inc$6K
- Contura, Inc.$6K
- Sumitomo Pharma America, Inc.$2K
- Medtronic$1K
- plus $5K from 34 others
Across 2 payments — averaging $701.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1K
What the payments were for
- Consulting fees$14,80026%
- Speaking & faculty fees$29,15651%
- Travel & lodging$4,7818%
- Food & beverage$7,47813%
- Education$5821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $23,818 |
| Axonics, Inc. | 32 | $13,588 |
| Urovant Sciences Inc | 26 | $5,577 |
| Contura, Inc. | 3 | $5,500 |
| Sumitomo Pharma America, Inc. | 18 | $2,261 |
| Medtronic(2 entities) | 23 | $1,475 |
| Astellas Pharma US Inc | 64 | $1,089 |
| Pfizer | 39 | $537 |
| Johnson & Johnson(2 entities) | 16 | $404 |
| Coloplast | 8 | $360 |
| 180 Medical, Inc. | 15 | $281 |
| Bayer | 16 | $274 |
| Antares Pharma, Inc. | 11 | $239 |
| Dendreon Pharmaceuticals LLC | 10 | $173 |
| Caldera Medical, Inc | 1 | $133 |
| Urogen Pharma, Inc. | 6 | $112 |
| Endo USA, Inc. | 4 | $97 |
| Tolmar Pharmaceuticals, Inc. | 5 | $89 |
| Merck | 3 | $85 |
| Myriad Genetic Laboratories, Inc. | 5 | $78 |
| Ferring Pharmaceuticals Inc. | 3 | $70 |
| Neotract Inc. | 1 | $60 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $58 |
| Teleflex LLC | 3 | $52 |
| Dentsply IH Inc. | 1 | $52 |
| Halozyme Inc | 2 | $47 |
| Myovant Sciences Inc. | 3 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $28 |
| Dentsply IH AB | 1 | $27 |
| Tolmar, Inc. | 1 | $24 |
| Boston Scientific | 1 | $22 |
| Agiliti Surgical, Inc. | 1 | $22 |
| Amgen | 1 | $20 |
| Laborie Medical Technologies Corp. | 1 | $18 |
| ABC Home Medical Supply, Inc. | 1 | $17 |
| Mission Pharmacal Company | 1 | $16 |
| Innovation Technologies Inc | 1 | $16 |
| Clarus Therapeutics Inc. | 1 | $14 |
| Cook Medical LLC | 1 | $11 |
| Therapeuticsmd, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$56,796 in reported general payments places this provider in the 95th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 76 | $66,310 |
| MyrbetriqMirabegron | 90 | $64,999 |
| Estradiol | 216 | $15,295 |
| PremarinEstrogens, Conjugated | 29 | $12,318 |
| EstringEstradiol | 12 | $6,351 |
| Potassium Citrate ErPotassium Citrate | 12 | $1,743 |
| Trospium Chloride | 12 | $627 |
| Tamsulosin Hcl | 28 | $322 |
| Hydroxyzine Hcl | 11 | $247 |
| Doxycycline Hyclate | 13 | $136 |
| Ciprofloxacin Hcl | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $2,261 | $66,31076 claims |
| Astellas Pharma US IncMyrbetriq | $1,089 | $64,99990 claims |
| PfizerPremarin, Estring | $537 | $18,66941 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 196 urology providers in South Carolina.
Other urology in Florence
- James OkellyFlorence$8K
- Brian EvansFlorence$8K
- Neal ShoreMyrtle Beach$3.2M
- Manish PatelElgin$213K
- Sandip PrasadCharleston$177K
- Benjamin DropkinGreenville$65K
- Ian MarshallCharleston$60K
- Thomas KeaneCharleston$52K
- Abhishek SrivastavaMyrtle Beach$41K
- William BogacheMyrtle Beach$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.